The past decade has yielded substantial evidence that the gut microbiome modulates brain function, including for instance behaviors relevant to anxiety and depression, pointing to a need to identify the biological pathways involved. In 2013 Clarke and colleagues reported that the early-life microbiome regulates the hippocampal serotonergic system in a sex-dependent manner, findings that opened up numerous lines of inquiry on the effects of the microbiome on neurodevelopment and behavior.
In the early 2000s evidence was mounting for a link between the gut microbiome and stress-related behaviors. Based on longstanding associations of psychological stress with gastrointestinal disorders, Bailey and Coe [1] revealed that early-life stress alters the composition of the gut microbiota in rhesus monkeys and that these changes in the microbiota correlate with anxiety-related behaviors and serum levels of stress hormones. Sudo et al. [2] further demonstrated that mice raised devoid of microbial colonization (germ-free mice) exhibit elevated stress hormone responses and decreased hippocampal levels of brain-derived neurotrophic factor (BDNF), a protein important for neurogenesis, compared to conventionally colonized controls. These phenotypes were reversed by mono-colonizing germ-free mice with select gut bacteria, revealing a causal role for the gut microbiota in regulating stress responses. In subsequent years several investigators, including Neufeld et al. [6] , extended these studies by examining various models including germ-free or antibiotictreated mice, rats, and zebrafish to demonstrate that changes in the gut microbiome alter stress-related behaviors across different organisms. To date, anxiety-associated changes in exploratory drive and risk avoidance have been the most frequently studied host behaviors in microbiota-gut-brain research.
While early work on microbial modulation of anxiety-related behaviors had revealed changes in stress hormones and brain BDNF levels, it seemed likely that additional neurotransmitter systems or modulators may underlie microbial alterations in host behavior, and insights into such pathways were at the time lacking. In 2009, a metabolomics study by Wikoff et al. [7] revealed deficiencies in serum serotonin and elevated serum tryptophan in germ-free mice compared to conventional controls. This was later corroborated by additional research indicating that the gut microbiota regulates peripheral serotonin levels (Sjögren et al. [8] , Yano et al. [9] ). Serotonin is a hormone and excitatory neurotransmitter that is produced in large quantities in the gastrointestinal tract, but is most prominently known for its central contributions to anxiety and depression. Whether microbial effects on the peripheral serotonergic system were similarly seen in the central serotonergic system had not been explored.
The study by Clarke et al. pioneered the efforts to examine effects of the microbiome on the brain serotonergic system [10] . It found that germ-free mice display increased levels of hippocampal serotonin, hippocampal 5-hydroxyindoleacetic acid (5-HIAA, the main catabolic product of serotonin), plasma tryptophan, and decreased tryptophan metabolism to kynurenine, as measured by HPLC. This was correlated with decreased expression of hippocampal BDNF. These latter findings corroborated previous studies [4, 7] by replicating germ-free increases in peripheral tryptophan and decreases in hippocampal BDNF expression, respectively.
In addition to revealing a link between the gut microbiota and brain serotonin, the Clarke et al. study also highlighted the importance of considering sex in microbiota-gut-brain studies. At the time many studies involving the microbiota 
